Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2008 Results
Date:8/5/2008

m Endu totaled RMB126.9 million (US$18.5 million), an increase of 27.8% compared to RMB99.3 million in the first six months of 2007.

Revenue from first-to-market Edavarone injection products under the brand names Bicun and Yidasheng totaled RMB147.6 million (US$21.5 million) in the second quarter of 2008, an increase of 34.3% compared to RMB109.9 million for the same period in 2007. For the first six months of 2008, revenue from Bicun and Yidasheng totaled RMB299.7 million (US$43.7 million), an increase of 57.5% compared to RMB190.3 million in the first six months of 2007.

Revenue from other first-to-market products, Jiebaishu and Sinofuan, totaled RMB10.1 million (US$1.5 million) in the second quarter of 2008. For the first six months of 2008, revenue from other first-to-market products totaled RMB13.4 million (US$2.0 million). There was no revenue generated from these two products for the same period in 2007.

Revenue from other branded generic products totaled RMB215.0 million (US$31.3 million) in the second quarter of 2008, an increase of 34.2% compared to RMB160.2 million for the same period in 2007. For the first six months of 2008, revenue from other branded generic products totaled RMB388.8 million (US$56.7 million), an increase of 10.1% compared to RMB353.1 million in the first six months of 2007.

Gross margin for the second quarter of 2008 decreased to 81.7%, as compared to 83.7% for the same period in 2007. The decrease was primarily due to the growth in other branded generics as a percentage of our total sales and the increased cost of some raw materials. For the first six months of 2008, gross margin decreased slightly to 82.4% compared to 82.7% for the first six months of 2007.

Research and development expenses for the second quarter of 2008 totaled RMB13.2 million (US$1.9 million), a decrease of 31.7% from RMB19.3 million for the corresponding period a year ago. As a percentage of total revenue, research and developme
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
9. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... Parents of teenaged and adolescent children ... the latest post discusses Teen Violence Related to Substance ... Dating Violence Awareness Month, the substance abuse treatment center ... help parents identify if there may be problems with ... drugs or alcohol. , “People learn how to establish ...
(Date:4/1/2015)... 01, 2015 OSF Saint Paul Medical ... System , was welcomed into the Ministry April 1, ... Msgr. Paul E. Showalter, vicar general of the Catholic ... Dedication culminated a nearly year-long transition process for the ... hospital. Speakers for the morning ceremony included Sister Judith ...
(Date:4/1/2015)... Miramar, FL (PRWEB) April 01, 2015 ... has received Provisional Certificate of Authority (PCOA) approval from ... important step in the ongoing development of a retirement ... enrich individual health, wellness and spiritual development. , America’s ... prepared to meet the housing needs of seniors, according ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Aging2.0 ... care, today announces the launch of the Aging2.0 ... senior care stakeholders and technology companies. The announcement was ... (NIC) Capital and Business Strategies Forum in San ... the new Alliance program is now open for additional ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 eMindful ... the expansion of its executive team with the addition ... digital officer. , In his new role, ... and user interface across the business and consumer portals. ... and building the company’s online community. His hiring ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Issues Toolkit for Teen Violence Related to Substance Abuse 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3
... Alzheimers disease (AD) has lately been suggested to be ... An increasing volume of evidence indicates that AD is ... important markers in tests of given pathophysiological hypotheses. ... Szeged, Hungary, hypothesized that the onset of AD affects ...
... retirement age has revealed that workers who retire early have ... until they reach 65. //This finding disapproves the existing misconception ... and happier lives as a consequence. ,Men were ... women, as were those on lower incomes compared to those ...
... with the outcome of botulinum-a toxin (BTX-A) detrusor ... overactivity. BTX-A detrusor injections have been described in ... spinal cord injury. ,Researchers from Germany ... successfully in children with a neurogenic bladder. After ...
... by Synovate India and sponsored by Colgate-Palmolive (India) Ltd says ... latest toothpaste available in the market, //the level of oral ... surveyed admitted that they have never been to a dentist ... oral hygiene practices are resulting in a myriad of dental ...
... Health Organization survey reveals that currently more than 5.13 ... more and more number of cases being reported each ... hospitals across the country. ,The priority of ... from falling prey to the disease. Inorder to increase ...
... have found that daily gargling with povidione-iodine reduced the chances ... been published in the American Journal of Preventive Medicine. ... the age group of 18 to 65. , ,The ... gargled water with povidone-iodine, the second group gargled with water ...
Cached Medicine News:Health News:Age-Dependent Alterations Not Specific For Alzheimers Disease 2Health News:A New Approach In Treatment Neurogenic Detrusor Overactivity In Children 2Health News:Condom Vending Machines To Be Installed Across Indian States 2Health News:Daily Gargling May Prevent Common Colds 2
(Date:4/1/2015)... , April 1, 2015 MEI Pharma, Inc. ... clinical development of novel therapies for cancer, announced today that ... Officer, will present at the 14 th Annual Needham ... Eastern time from the Westin Grand Central Hotel in ... presentation can be accessed at www.meipharma.com . A replay ...
(Date:4/1/2015)... , April 1, 2015  Salix Pharmaceuticals, ... Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX:VRX), ... the outstanding $750,000,000 aggregate principal amount of its ... U8639TAA3 (the " Notes ") pursuant to two ... $262,500,000 aggregate principal amount of the Notes, and ...
(Date:4/1/2015)... April 1, 2015   AMC Health , a ... advances in monitored care that are transforming chronic care ... 2015 Conference. The conference will be held at ... April 12 through 16. In addition to demonstrating its ... AMC Health will share innovations that transform the way ...
Breaking Medicine Technology:MEI Pharma to Present at Needham Healthcare Conference 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 2AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 3AMC Health Demonstrates Advances in Monitored Care at HIMSS 2015 4
... (Otix) (Nasdaq: OTIX ), a leading provider of ... decided to discontinue its operations in Germany as of September ... CEO of Otix stated, "the regulatory obstacles in Germany have ... as a result, we have made the decision to discontinue ...
... announced this week that it has received the Japanese ... collection and transfer of biological samples. The Japanese flocked ... growing number of patents held by COPAN across the ... and transfer of biological samples, including the Australian patent ...
Cached Medicine Technology:Otix Global, Inc. to Discontinue German Operations 2Otix Global, Inc. to Discontinue German Operations 3COPAN Secures Japanese Patent for its Flocked Swab Innovation 2
... The NexGen Legacy LCCK Femoral ... require additional prosthetic stabilization due to ... function, and require augmentation and/or stem ... The NexGen LCCK is available with ...
... manufacturers focus attention on implant design, one ... Profix Total Knee System seeks to establish ... system and the tools to implant them. ... recognized for innovation in total knee instrumentation, ...
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
Medicine Products: